At Claya, your journey begins with a comprehensive telehealth consultation with one of our board-certified medical providers
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
This reveals whether L-carnitine supplementation addresses a real metabolic limitation in your biology, eliminating wasteful trial-and-error and ensuring every addition to your protocol serves a specific, evidence-based purpose
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate
Accessed 6 Apr 2025
Expect jaundice, elevated direct bilirubin, elevated ALP, and possibly elevated ALT/AST